arrow
A

Alejandro Gutiérrez

Hospital Universitario Puerta del Mar
H指数:19
被引数:1,696

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Persisting Sex Discrepancies in Short-Term Outcomes of Patients with ST-Segment Myocardial Infarction: Results of the ISACS-STEMI COVID-19 Registry

ST段抬高型心肌梗死患者短期结局中的持续性性别差异:ISACS-STEMI COVID-19登记研究的结果

2026-05-070
OAAI
Use of the win ratio approach to assess outcomes in the DapaTAVI trial
2026-03-013
PRE
Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

达格列净对接受经导管主动脉瓣植入术的主动脉瓣狭窄患者生活质量的影响

JACC
IF0
2025-10-060
PRE
ESP-INOCA: Rationale and design of a national multicentre registry for prognostic stratification in patients with suspected myocardial ischaemia and non-obstructive coronary arteries

ESP-INOCA:建立全国多中心登记研究以对疑似心肌缺血伴非阻塞性冠状动脉患者的预后进行分层的合理性与设计方案

2025-08-290
PRE
Rationale and design of European microCirculatory Resistance and Absolute Flow Team: The Euro-CRAFT Registry

欧洲微循环阻力与绝对血流团队:Euro-CRAFT 注册研究的原理与设计

2025-08-270
PRE
Validation of the Zwolle Risk Score in STEMI Patients Undergoing Primary PCI: Insights from the ISCAS-STEMI COVID-19 Registry

Zwolle风险评分在行急诊PCI的STEMI患者中的验证:来自ISCA-STEMI COVID-19登记研究的数据

2025-04-160
PRE
Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry
2024-10-110
PRE
Efficacy of a Mobile Health App (eMOTIVA) Regarding ComplianceWith Cardiac Rehabilitation Guidelines in Patients With CoronaryArtery Disease:Randomized Controlled Clinical Trial

移动健康应用程序 (eMOTIVA) 对冠状动脉疾病患者遵守心脏康复指南的疗效: 随机对照临床试验

2024-07-251
OAAI
Effectiveness of an Interactive mHealth App (EVITE) in Improving Lifestyle After a Coronary Event: Randomized Controlled Trial

交互式mHealth应用程序 (EVITE) 在改善冠状动脉事件后生活方式中的有效性: 随机对照试验

2024-04-220
OAAI
Treatment of Slow-Flow After Primary Percutaneous Coronary Intervention With Flow-Mediated Hyperemia: The Randomized RAIN-FLOW Study
2023-07-044
OAAI
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry

新型冠状病毒肺炎大流行对STEMI的机械再灌注和30天死亡率的年龄相关影响: isacs-stemi新型冠状病毒肺炎注册表的结果

2023-03-083
OAAI
Spontaneous coronary artery dissection and ST-segment elevation myocardial infarction: Does clinical presentation matter?

自发性冠状动脉夹层和ST段抬高型心肌梗死: 临床表现重要吗?

2023-02-013
PRE
Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry
2023-01-230
OAAI
Endothelial dysfunction in patients with angina and non-obstructed coronary arteries is associated with an increased risk of mayor cardiovascular events. Results of the Spanish ENDOCOR registry

心绞痛和非阻塞冠状动脉患者的内皮功能障碍与主要心血管事件的风险增加有关。西班牙ENDOCOR注册表的结果

2023-01-017
PRE
Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS-STEMI COVID-19 Registry
2022-11-134
OAAI
Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19 A Randomized Clinical Trial

高流量氧疗与常规氧疗对重症COVID-19患者有创机械通气及临床恢复影响的随机临床研究

2021-12-07186
OA
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction
HEART
IF4.4
2021-10-2831
OA